scholarly article | Q13442814 |
P50 | author | Gianfranco Parati | Q37830585 |
Francesco Della Rosa | Q55294545 | ||
P2093 | author name string | Mario Facchini | |
Gabriella Malfatto | |||
Alessandra Villani | |||
Alessia Giglio | |||
Giovanna Branzi | |||
Alfredo Corticelli | |||
P2860 | cites work | Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization | Q22306353 |
Structured telephone support or telemonitoring programmes for patients with chronic heart failure | Q24236592 | ||
Noninvasive assessment of hemodynamics: an emphasis on bioimpedance cardiography | Q34010572 | ||
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events | Q34933316 | ||
Doppler echocardiographic assessment of valvar regurgitation | Q34998554 | ||
Key role of congestion in natural history of heart failure | Q35178827 | ||
Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure | Q35203186 | ||
Ultrasound lung comets: a clinically useful sign of extravascular lung water. | Q36406089 | ||
Congestion is an important diagnostic and therapeutic target in heart failure | Q36586465 | ||
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology | Q36811824 | ||
State of the art: using natriuretic peptide levels in clinical practice | Q37257460 | ||
Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial | Q37299742 | ||
Theodore E. Woodward Award: Coming in out of the rain. Relieving congestion in heart failure | Q37348166 | ||
Recommendations for the evaluation of left ventricular diastolic function by echocardiography | Q37383745 | ||
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial | Q38383948 | ||
Quantitation of mitral regurgitation: rationale, approach, and interpretation in clinical practice. | Q42776568 | ||
Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality | Q42781665 | ||
Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality | Q42946298 | ||
BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status | Q43281249 | ||
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial | Q43549494 | ||
Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure | Q45056505 | ||
Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting | Q46456287 | ||
Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department | Q46561355 | ||
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. | Q47845346 | ||
Transthoracic bioimpedance and brain natriuretic peptide levels accurately indicate additional diastolic dysfunction in patients with chronic advanced systolic heart failure | Q48159181 | ||
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study | Q48194485 | ||
B-type natriuretic peptide-guided heart failure therapy: A meta-analysis | Q48263615 | ||
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction | Q48563810 | ||
Transthoracic impedance accurately estimates pulmonary wedge pressure in patients with decompensated chronic heart failure | Q48692747 | ||
Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology | Q57217185 | ||
Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure | Q57652894 | ||
The limited reliability of physical signs for estimating hemodynamics in chronic heart failure | Q69940116 | ||
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations | Q73736775 | ||
Plasma brain natriuretic peptide--an independent predictor of cardiovascular mortality in acute heart failure | Q74152405 | ||
Reproducibility of impedance cardiography hemodynamic measures in clinically stable heart failure patients | Q74171709 | ||
Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation | Q80843566 | ||
Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure | Q83450686 | ||
??? | Q24657222 | ||
P433 | issue | 2 | |
P921 | main subject | heart failure | Q181754 |
systole | Q496359 | ||
P304 | page(s) | 103-109 | |
P577 | publication date | 2013-02-03 | |
P1433 | published in | Clinical Cardiology | Q4502312 |
P1476 | title | Transthoracic bioimpedance and brain natriuretic peptide assessment for prognostic stratification of outpatients with chronic systolic heart failure | |
P478 | volume | 36 |
Search more.